Friday 20 August | |
Kingspan Group PLC | Half Year Results |
Monday 23 August | |
BATM Advanced Communications Ltd | Half Year Results |
IG Design Group PLC | Trading Statement |
Up Global Sourcing Holdings PLC | Trading Statement |
Tuesday 24 August | |
Benchmark Holdings PLC | Q3 Results |
John Wood Group PLC | Half Year Results |
PureTech Health PLC | Half Year Results |
Wednesday 25 August | |
Anglo Pacific Group PLC | Half Year Results |
Clipper Logistics PLC | Full Year Results |
Costain Group PLC | Half Year Results |
CPPGroup PLC | Half Year Results |
Grafton Group PLC | Half Year Results |
Thursday 26 August | |
Chesnara PLC | Half Year Results |
CRH PLC | Half Year Results |
Faron Pharmaceuticals Oy | Half Year Results |
Glenveagh Properties PLC | Half Year Results |
Hays PLC | Full Year Results |
Hunting PLC | Half Year Results |
Irish Continental Group PLC | Half Year Results |
Macfarlane Group PLC | Half Year Results |
Malin Corp PLC | Half Year Results |
Polymetal International PLC | Half Year Results |
Copyright 2021 Alliance News Limited. All Rights Reserved. |
IN BRIEF: Malin Corp investee signs agreement with Astellas Pharma
Malin Corp PLC - Dublin-based investor in life sciences companies - Investee company Poseida Therapeutics Inc enters into a research collaboration and licensing agreement with Xyphos Biosciences Inc, a wholly owned subsidiary of Astellas Pharma Inc. Says agreement is to develop novel convertibleCAR programs by combining the innovative cell therapy platforms from each of the companies.
Read more